PLANT
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PLANT - overview
Established
2020
Location
Seongnam, -, South Korea
Primary Industry
Materials
About
PLANT, based in South Korea, specializes in plant-based collagen products, offering health-conscious consumers innovative solutions for skin, hair, and overall wellness. Founded in 2020 in Seongnam, South Korea, Rawga Inc. , trading under the name PLANT, focuses on developing plant-based health supplements. The company has not undergone significant pivots in its operations.
It has secured KRW 15. 5 billion in series B funding from returning investor KB Investment. The founder's history is not provided. PLANT delivers a variety of plant-based collagen products aimed at health-conscious consumers.
Its primary offerings include liquid collagen, biotin-infused jelly, and effervescent powder, each designed to promote skin health, support hair and nail vitality, and enhance overall wellness, featuring ultra-low molecular weight peptides and essential vitamins for improved absorption. PLANT generates revenue through direct-to-consumer sales and partnerships with health and wellness retailers. Products are distributed online via their website and through retail collaborations, with flagship items like liquid collagen and biotin jelly sold on a per-unit basis, reflecting the company's commitment to quality in the health supplement sector. The company will use the May 2026 funding to to speed up its shift to natural product-based peptides.
Current Investors
KB Investment, SOSV, Hanwha Investment & Securities
Primary Industry
Materials
Sub Industries
Beauty & Hygiene, Health Foods & Nutritional Supplements, Dermatology, Biopolymer Materials
Website
www.plantbyseed.com/
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
PLANT - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|
| Revenue (USD) | 1,250,000 | 189,331,000 | - | - | - |
| % Revenue Growth (YoY) | - | 15046.5% | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | (2,616,000) | (54,431,000) | - | - | - |
| Operating Margin | (209.3%) | (28.7%) | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (2,612,000) | (95,929,000) | - | - | - |
| % Net Margin | (209.0%) | (50.7%) | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.